MYC and Mobius syndrome: C-Myc gene amplification is a defining feature of Group 3 MBs and occurs in ~17% of the tumors.11 Patients with C-Myc-amplified MBs suffer from an extremely shorter 5-year survival rate of 20%,75,76 implying C-Myc as an important pro-malignant driver in MBs.